Thursday, June 20, 2024
HomeBusinessAutoinjectors Market to accelerate at 6.57% CAGR, USD 8.35 Bn incremental growth...

Autoinjectors Market to accelerate at 6.57% CAGR, USD 8.35 Bn incremental growth expected during the forecast period | ZMR

Autoinjectors MarketAn autoinjector is a syringe-like device with a pre-discharged drug dosage and a spring-charged needle. When a specified amount of medicine is pushed into the body in a sliding action, autoinjectors are employed. The devices are mostly used for self-administering epinephrine to prevent anaphylaxis in migraine sufferers (to provide instant pain relief), as well as medical and emergency treatments. The majority of Autoinjectors are single-loaded, single-use, disposable syringes. Autoinjector devices can be simple to use, self-administered by patients, and delivered by unskilled persons, depending on the design.

Covid-19 Impact and Recovery Analysis: Auto-injectors Market

We’ve been keeping an eye on COVID-19’s direct impact on this market, as well as its indirect impact on other industries. From a global and regional perspective, this study examines the impact of the pandemic on the auto-injectors industry. The study categorises the Auto-injectors industry by type, application, and consumer sector to determine market size, market characteristics, and market growth. It also includes a thorough examination of the factors that influenced market development before and after the Covid-19 pandemic. In addition, Report conducted a PESTEL analysis in the industry to investigate key influencers and entry barriers.

Insights on the Autoinjectors Market

North America, Europe, Asia-Pacific, and the Rest of the World are the regions analysed in the worldwide Autoinjectors market. In the current environment, North America tends to lead the global market in terms of revenue share. During the forecast term, it is expected to maintain its superiority. North America’s dominance, on the other hand, will be openly challenged by the European market. Factors such as the rising prevalence of chronic diseases like diabetes and multiple sclerosis, the growing availability of generic auto-injectors, and favourable reimbursement rules are all contributing to this dominance.

Several recent developments, such as product introductions, are also propelling market expansion. For example, Teva Pharmaceuticals announced the launch of an Autoinjector for Ajovy injection in the United States on April 27, 2020. Otsuka Pharmaceutical Co., Ltd. also received manufacturing and marketing approval for the AJOVY Subcutaneous Injection 225 mg autoinjector in Japan on July 8, 2021. Furthermore, Sandoz announced the retail introduction of SYMJEPITM (epinephrine) 0.3 mg and 0.15 mg Injections in the United States on July 9, 2019. Symjepi is a single-dose, pre-filled device and device combination that can be used instead of epinephrine autoinjectors to treat allergic responses in an emergency.

Market Drivers and Barriers for Autoinjectors

Because of the rising prevalence of diabetic cases and chronic conditions such as multiple sclerosis, there will be an increase in demand for autoinjectors. Apart from these factors, the market for Autoinjectors is growing due to an increase in technologically advanced Autoinjectors, an increase in the incidence of anaphylactic shock, an increase in awareness of Autoinjectors, and the convenience of use of self-administering injection.

Alternative invasive and painful drug delivery systems, as well as single-designed autoinjectors for numerous medication doses, are some of the Autoinjector market’s drawbacks. Due to the outbreak of COVID-19, which resulted in factors such as lockdown restrictions, patient reluctance to visit hospitals and clinics, logistical restrictions, unavailability of medical devices, and the closure of manufacturing facilities, the market for autoinjectors had experienced a period of stagnant growth.

Key Companies:  BD, Ysmoed AG, Sonceboz, Phillips-Medisize, Nemera, Novartis, Teva Pharmaceuticals, Amgen, GSK, Mylan Inc, Elcam Medical, Union Medico Injection Safety ApS, SHL Medical AG, Haselmeier, Owen Mumford Ltd

The following is the segmentation outline from Zion Market Research’s recent study on the Autoinjectors Market:

By Type

● Reusable Autoinjectors

● Disposable Autoinjectors

By Application

● Hospitals & Clinics

● Home Care Settings

● Ambulatory Care Settings

What Can You Expect From This Auto-Injectors Market Report ?

• When you have information on the value of production, cost of production, and value of products over the next five years, you may formulate development strategies for your company.

• A comprehensive review of regional distributions and popular product kinds in the market.

• How do the market’s top corporations and mid-level firms make money?

• Calculate the cost of entry for new players who want to join the industry.

• Detailed analysis of the Auto-injectors Market’s overall expansion to assist you in deciding on product launches and asset developments.

About Us :

Zion Market Research is an obligated company. We create futuristic, cutting edge, informative reports ranging from industry reports, company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database.


Most Popular

Recent Comments